Press release
Pancreatic Cancer’s therapeutic pipeline review in 2015
This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team.
This report provides comprehensive information on the therapeutic development for Pancreatic Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pancreatic Cancer and special features on late-stage and discontinued projects.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope of report;
- The report provides a snapshot of the global therapeutic landscape of Pancreatic Cancer
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Pancreatic Cancer and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Pancreatic Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Pancreatic Cancer pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Key Topics Covered:
• Pancreatic Cancer Overview
• Therapeutics Development
• Pancreatic Cancer - Therapeutics under Development by Companies
• Pancreatic Cancer - Therapeutics under Investigation by Universities/Institutes
• Pancreatic Cancer - Pipeline Products Glance
• Pancreatic Cancer - Products under Development by Companies
• Pancreatic Cancer - Products under Investigation by Universities/Institutes
• Pancreatic Cancer - Companies Involved in Therapeutics Development
• Pancreatic Cancer - Therapeutics Assessment
• Drug Profiles
• Pancreatic Cancer - Recent Pipeline Updates
• Pancreatic Cancer - Dormant Projects
• Pancreatic Cancer - Discontinued Products
• Pancreatic Cancer - Product Development Milestones
Companies Mentioned
3-V Biosciences, Inc.
3B Pharmaceuticals GmbH
4SC AG
AB Science
AbbVie Inc.
AbGenomics International, Inc.
Ability Pharma, SL
Adamed Sp. z o.o.
Adamis Pharmaceuticals Corporation
Aduro BioTech, Inc.
Advantagene, Inc.
Advaxis, Inc.
AGV Discovery, SAS
AIMM Therapeutics B.V.
Alchemia Limited
Alethia Biotherapeutics Inc.
Allinky Biopharma
Almac Discovery Limited
Altor BioScience Corporation
Ambrx, Inc.
Ambryx Biotechnology, Inc.
Amgen Inc.
Anavex Life Sciences Corp.
ANP Technologies, Inc.
APEIRON Biologics AG
Apexigen, Inc.
Aphios Corporation
For more information visit: https://marketreportscenter.com/reports/1058/pancreatic-cancer-pipeline-review-h1-2015
Contact Us;
Sam Collins
Market Reports Center
1-646-883-3044 (US)
+91- 20-41217796 (IND)
info@marketreportscenter.com
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. Market Reports Center’s team consistently works to update and extend our existing repository of market research reports by partnering with new publishers and adding their studies to our website.
Market Reports Center
Survey 48, Pune, MH, India, 411038
1-646-883-3044 (US)
+91- 20-41217796 (IND)
info@marketreportscenter.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Cancer’s therapeutic pipeline review in 2015 here
News-ID: 327009 • Views: …
More Releases from Market Reports Center
Youth Sports Video Equipment Market poised to reach $5.5 billion by 2024
The report by Market Reports Center on “Youth Sports Video Equipment: Market Shares, Strategy, and Forecasts, Worldwide, 2019to 2024. The 2019study has 225 pages, 115 tables and figures.
Check the discount on report at https://marketreportscenter.com/request-discount/610168
Youth sports teams are being created that leverage video to provide a quality experience for the youthful participants, coaches, and parents. Demand for more video for youth teams comes from a change in the way youth…
Alcohol Testers and Drug Tester Equipment Market poised to reach $4.7 billion by …
The report by Market Reports Center on “Alcohol Testing And Drug Testing Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2019 to 2025” that highlights the in-depth market analysis and covers significant data with future prospects of the market. The 2019 study has 348 pages, 102 tables and figures. Worldwide markets are poised to achieve significant growth as law enforcement and companies test for substance abuse. Worldwide markets are poised to…
By 2024, Blood products to reach $57.5 billion, reflecting a 5 year CAGR of 8.2% …
A new study “Blood Plasma: Market Shares, Strategies, and Forecasts, Worldwide, 2018 to 2024” says sales of blood therapeutics were $30.9 billion in 2017. By 2024, Blood products to reach $57.5 billion, reflecting a 5 year CAGR of 8.2%.
Worldwide markets are poised to achieve continuing growth as animal and human blood is further fractionated to address more disease treatments and becomes more effective in the research and development aspects of…
Global Toxicology Services Market 2018 by Manufacturers, Regions, Type and Appli …
Latest Report at Market Reports Center analyzes the Toxicology Services Market, and says that Toxicology Services Market estimates the steady growth with extensive Compound Annual Growth Rate (CAGR) during the forecast period. Report helps to identify and cover related to product and applications by new market discoveries.
Get Sample Report at- https://marketreportscenter.com/request-sample/603270
How will report help you?
This market research report provides a detailed analysis of the global Toxicology Services Market with…
More Releases for Pancreatic
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025
Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025
Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025
Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Pancreatic Market to Insight By 2025: Top Key Vendors
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and…
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.
Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,…
